✦ LIBER ✦

Effects of anti-CD154 treatment on B cells in murine systemic lupus erythematosus

✍ Scribed by Xiaobo Wang; Weiqing Huang; Lena E. Schiffer; Masahiko Mihara; Alla Akkerman; Kenji Hiromatsu; Anne Davidson

Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 144 KB
Volume: 48
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.10929

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effect of anti-CD40 ligand antibody

The effect of anti-CD40 ligand antibody on B cells in human systemic lupus erythematosus

✍ Weiqing Huang; Jayashree Sinha; Jeffrey Newman; Bhoompally Reddy; Lalbachan Budh 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 1 views

Distinct mechanisms of action of anti-CD

Distinct mechanisms of action of anti-CD154 in early versus late treatment of murine lupus nephritis

✍ Sergio A. Quezada; Maria Eckert; Oyedele A. Adeyi; Alan R. Schned; Randolph J. N 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 306 KB 👁 1 views

Treatment of systemic lupus erythematosu

Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD154: A randomized, double-blind, placebo-controlled trial

✍ Kenneth C. Kalunian; John C. Davis Jr.; Joan T. Merrill; Mark C. Totoritis; Davi 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 1 views

Loss of susceptibility of B cells to ant

Loss of susceptibility of B cells to anti-Fab antibodies in systemic lupus erythematosus

✍ Hiroshi Suzuki; Takehiko Sakurami; Hiroo Imura 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 1 views

Expression and occupancy of BAFF-R on B

Expression and occupancy of BAFF-R on B cells in systemic lupus erythematosus

✍ Robert H. Carter; Hong Zhao; Ximeng Liu; Marc Pelletier; Winn Chatham; Robert Ki 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB 👁 2 views

Effects of short-term infliximab therapy

Effects of short-term infliximab therapy on autoantibodies in systemic lupus erythematosus

✍ Martin Aringer; Günter Steiner; Winfried B. Graninger; Elisabeth Höfler; Carl W. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB 👁 1 views

Objective. To analyze changes in autoantibodies occurring in patients with systemic lupus erythematosus (SLE) treated with 4 infusions of the chimeric anti-tumor necrosis factor ␣ (TNF␣) antibody infliximab. Methods. In an open-label safety study, 7 patients with SLE were treated with infliximab at